A detailed history of Acorns Advisers, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Acorns Advisers, LLC holds 14,492 shares of PFE stock, worth $363,459. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,492
Previous 12,503 15.91%
Holding current value
$363,459
Previous $303,000 21.78%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$23.29 - $25.88 $46,323 - $51,475
1,989 Added 15.91%
14,492 $369,000
Q2 2025

Aug 13, 2025

BUY
$21.59 - $24.84 $66,648 - $76,681
3,087 Added 32.78%
12,503 $303,000
Q1 2025

May 20, 2025

BUY
$25.01 - $27.13 $22,333 - $24,227
893 Added 10.48%
9,416 $239,000
Q4 2024

Feb 13, 2025

BUY
$24.8 - $30.19 $211,370 - $257,309
8,523 New
8,523 $226,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $141B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Acorns Advisers, LLC Portfolio

Follow Acorns Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acorns Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acorns Advisers, LLC with notifications on news.